Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5 By Tom Howell Jr. - The Washington Times Shares
Florida cancels 2,000 monoclonal treatment appointments after FDA move By Tom Howell Jr. - The Washington Times Shares
FDA and its flimsy COVID-19 FOIA dodge falls flat with federal judge By Cheryl K. Chumley - The Washington Times Shares
Calls to upgrade masks intensify as omicron spreads By Valerie Richardson - The Washington Times Shares
FDA clears Pfizer COVID booster for ages 12 to 15, shortens wait time for others amid omicron By Tom Howell Jr. - The Washington Times Shares
U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19 By Matthew Perrone - Associated Press Shares
FDA authorizes Pfizer COVID-19 pill for emergency use By Tom Howell Jr. - The Washington Times Shares
U.S. regulators lift in-person restrictions on abortion pill By Matthew Perrone - Associated Press Shares
FDA pick Robert Califf pledges to make COVID-19 task ‘No. 1’ By Tom Howell Jr. - The Washington Times Shares
FDA to the public: We will be nimble in response to omicron By Tom Howell Jr. - The Washington Times Shares
Some Old Spice and Secret deodorants and sprays recalled By Shen Wu Tan - The Washington Times Shares
One-third of Alzheimer’s patients using approved drug see brain swelling: study By Shen Wu Tan - The Washington Times Shares
Maryland expands eligibility for booster shots to all adults By Shen Wu Tan - The Washington Times Shares
FDA authorizes Pfizer-BioNTech and Moderna COVID-19 boosters for all adults By Tom Howell Jr. - The Washington Times Shares
Biden nominates Robert Califf to lead the FDA once more By Jeff Mordock - The Washington Times Shares
Pfizer’s booster request sets up a pivotal decision for FDA By Tom Howell Jr. - The Washington Times Shares
Pfizer to seek FDA authorization of COVID-19 pill by Thanksgiving By Tom Howell Jr. - The Washington Times Shares
Teachers’ unions hail progress in COVID-19 vaccine for kids By Tom Howell Jr. - The Washington Times Shares